| 10/20/2026 3:05 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:06 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2026 3:07 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/13/2026 7:21 AM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/07/2026 3:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 4:05 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 4:06 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2026 3:40 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2026 3:11 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 3:26 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CORZ and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Core Scientific and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/10/2026 6:18 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/27/2026 6:07 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/26/2026 3:04 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/24/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2026 3:13 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/19/2026 3:05 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2026 11:13 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 08/14/2026 6:02 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/12/2026 3:37 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G/A | |
| 08/12/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/05/2026 3:40 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 08/04/2026 4:37 PM | Core Scientific (1839341) Subject Situational Awareness LP (2045724) Filed by | Form SCHEDULE 13D/A | |
| 07/31/2026 9:18 AM | Core Scientific (1839341) Subject VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by | Form SCHEDULE 13G | |
| 07/22/2026 3:10 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:16 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/20/2026 3:16 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/15/2026 4:41 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/06/2026 3:45 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/01/2026 6:17 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 6:18 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/10/2026 3:14 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/26/2026 3:19 PM | Core Scientific (1839341) Subject JANE STREET GROUP, LLC (1595888) Filed by | Form SCHEDULE 13G | |
| 05/26/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 3:20 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/15/2026 6:46 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 3:49 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 05/15/2026 11:29 AM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
Why tech stocks are dead (Ad) AI skeptics see dot-com era warning signs, and they have a point. But the real opportunity may not be in the big tech names pouring billions into data centers.
Walmart's $24 million satellite network, AMR's Sabre system, and Capital One's 36,114 pricing tests all prove the same thing: compute has always been business's biggest moat, and it's about to get cheaper than ever.
Porter Stansberry says one overlooked, government-protected sector is positioned to absorb this near-free compute boom and could become the next Magnificent 7. Watch Porter Stansberry's broadcast to see which sector could lead next |
| 05/13/2026 3:06 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/11/2026 3:03 PM | Core Scientific (1839341) Issuer Ray Jorge L. (2123780) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/06/2026 3:54 PM | Core Scientific (1839341) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/06/2026 3:15 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/06/2026 3:02 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 3:06 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/06/2026 6:52 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/29/2026 11:56 AM | Core Scientific (1839341) Subject VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by | Form SCHEDULE 13G | |
| 04/27/2026 4:30 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/23/2026 7:59 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/22/2026 3:01 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/21/2026 6:36 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/17/2026 8:50 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/16/2026 7:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 04/15/2026 3:02 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/08/2026 3:32 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:25 PM | Core Scientific (1839341) Issuer DUCHENE TODD M (1248745) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/02/2026 7:26 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/01/2026 3:44 PM | Core Scientific (1839341) Subject DUCHENE TODD M (1248745) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/31/2026 3:59 PM | Core Scientific (1839341) Filer | Form DEFA14A | |
| 03/31/2026 4:01 PM | Core Scientific (1839341) Filer | Form ARS | |
| 03/31/2026 3:55 PM | Core Scientific (1839341) Filer | Form DEF 14A | |
| 03/27/2026 5:45 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4/A | |
| 03/26/2026 4:39 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 7:29 AM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/20/2026 7:39 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/19/2026 3:06 PM | Core Scientific (1839341) Issuer Nygaard James P Jr (1842273) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/18/2026 4:14 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 03/12/2026 11:55 AM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 03/10/2026 3:08 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/06/2026 3:13 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/04/2026 8:05 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 03/02/2026 3:44 PM | Core Scientific (1839341) Filer | Form 10-Q/A | |
| 03/02/2026 3:18 PM | Core Scientific (1839341) Filer | Form 10-K/A | |
| 02/19/2026 8:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 02/19/2026 10:56 AM | Core Scientific (1839341) Filer | Form 8-K/A | |
| 02/18/2026 4:16 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/11/2026 10:11 AM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G/A | |
| 02/09/2026 5:08 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G/A | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Weiss Eric Stanton (2009491) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer CRAIN ELIZABETH (1604659) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Core Scientific (1839341) Issuer Levy Jordan (1541436) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:11 PM | Booth Jeffrey David (2009493) Reporting Core Scientific (1839341) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/26/2026 3:15 PM | Core Scientific (1839341) Issuer Sullivan Adam Taylor (1980208) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/20/2026 8:07 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 01/07/2026 1:59 PM | Core Scientific (1839341) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 01/02/2026 5:26 PM | Core Scientific (1839341) Issuer Rozov Yadin (1921268) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/18/2025 7:17 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years (Ad) Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis.
The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets.
Watch his free video breakdown and see the five steps he outlines for investors. Watch the free video and see his five steps now |
| 12/10/2025 5:12 PM | Citadel Securities GP LLC (1721695) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 12/01/2025 7:04 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/17/2025 5:35 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 11/13/2025 4:42 PM | Core Scientific (1839341) Subject SUSQUEHANNA SECURITIES, LLC (1446580) Filed by | Form SCHEDULE 13G/A | |
| 11/12/2025 3:05 PM | BARCLAYS PLC (312069) Filed by Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject | Form SCHEDULE 13G | |
| 11/03/2025 5:42 PM | Core Scientific (1839341) Subject Valiant Capital Management, L.P. (1452689) Filed by Valiant Capital Management, L.P. (1452689) Filed by | Form SCHEDULE 13G | |
| 10/31/2025 4:16 PM | Core Scientific (1839341) Subject Two Seas Capital LP (1823138) Filed by | Form SCHEDULE 13D/A | |
| 10/31/2025 3:27 PM | Core Scientific (1839341) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |